201 related articles for article (PubMed ID: 1427436)
61. Fusariosis and skin T cell lymphoma: concomitant more than a differential diagnosis.
Richetta AG; Lichtener M; Mattozzi C; Miccoli A; Giancristoforo S; D'Epiro S; Vullo V; Calvieri S
Clin Ter; 2010; 161(3):265-7. PubMed ID: 20589360
[TBL] [Abstract][Full Text] [Related]
62. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient.
Arrese JE; Piérard-Franchimont C; Piérard GE
Am J Dermatopathol; 1996 Apr; 18(2):196-8. PubMed ID: 8739996
[TBL] [Abstract][Full Text] [Related]
63. Fusarium brain abscess: case report and literature review.
Garcia RR; Min Z; Narasimhan S; Bhanot N
Mycoses; 2015 Jan; 58(1):22-6. PubMed ID: 25476184
[TBL] [Abstract][Full Text] [Related]
64. Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B.
Adami F; Scarin M; Pescarini L; Binotto G; Pavan L; Sgarabotto D; Semenzato G
Mycoses; 2011 Jul; 54(4):365-9. PubMed ID: 20406399
[No Abstract] [Full Text] [Related]
65. Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels.
Arning M; Kliche KO; Heer-Sonderhoff AH; Wehmeier A
Mycoses; 1995; 38(11-12):459-65. PubMed ID: 8720196
[TBL] [Abstract][Full Text] [Related]
66. Case report. Successful outcome of invasive nasal sinus zygomycosis in a child with relapsed acute lymphoblastic leukaemia due to liposomal amphotericin B.
Wali YA; al Lamki Z; al Kindi H; Taqi AM; Shah W; Soliman H; Zackaria M; al Okbi H
Mycoses; 2001; 44(5):195-9. PubMed ID: 11486458
[TBL] [Abstract][Full Text] [Related]
67. [Pulmonary mucormycosis in leukemic patients. Apropos of 2 cases].
Sastre JL; Pérez-Oteyza J; López J; Cerveró C; Sánchez-Sousa A; García-Laraña J; Cancelas JA; Odriozola J; Navarro JL
Sangre (Barc); 1994 Feb; 39(1):53-5. PubMed ID: 7515195
[TBL] [Abstract][Full Text] [Related]
68. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
Cornely OA; Leguay T; Maertens J; Vehreschild MJGT; Anagnostopoulos A; Castagnola C; Verga L; Rieger C; Kondakci M; Härter G; Duarte RF; Allione B; Cordonnier C; Heussel CP; Morrissey CO; Agrawal SG; Donnelly JP; Bresnik M; Hawkins MJ; Garner W; Gökbuget N;
J Antimicrob Chemother; 2017 Aug; 72(8):2359-2367. PubMed ID: 28575414
[TBL] [Abstract][Full Text] [Related]
69. Liposomal amphotericin B, AmBisome.
Hay RJ
J Infect; 1994 May; 28 Suppl 1():35-43. PubMed ID: 8077689
[TBL] [Abstract][Full Text] [Related]
70. Cutaneous Fusarium infection in an adolescent with acute leukemia.
Alvarez-Franco M; Reyes-Mugica M; Paller AS
Pediatr Dermatol; 1992 Mar; 9(1):62-5. PubMed ID: 1574478
[TBL] [Abstract][Full Text] [Related]
71. Disseminated fusariosis.
Repiso T; García-Patos V; Martin N; Creus M; Bastida P; Castells A
Pediatr Dermatol; 1996; 13(2):118-21. PubMed ID: 9122067
[TBL] [Abstract][Full Text] [Related]
72. [Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
Olivares R; Luppi M; Díaz MC
Rev Chilena Infectol; 2018 Aug; 35(4):448-452. PubMed ID: 30534934
[TBL] [Abstract][Full Text] [Related]
73. Factitious fungus in two children with cancer receiving liposomal amphotericin.
Fisher MJ; Guttenberg M; Kramer SS; Bell LM; Lange BJ
J Pediatr Hematol Oncol; 2002; 24(5):360-3. PubMed ID: 12142783
[TBL] [Abstract][Full Text] [Related]
74. Disseminated cutaneous and vascular invasion by Fusarium moniliforme in a fatal case of acute lymphocytic leukemia.
Smith AG; Bustamante CI; Wood C
Mycopathologia; 1993 Apr; 122(1):15-20. PubMed ID: 8326994
[TBL] [Abstract][Full Text] [Related]
75. Skin nodules in a patient with acute myeloid leukemia and neurological deterioration--quiz case. Disseminated fusariosis.
Rieger KE; Ridky TW; Sundram UN
Arch Dermatol; 2010 Sep; 146(9):1037-42. PubMed ID: 20855710
[No Abstract] [Full Text] [Related]
76. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years.
Musa MO; Al Eisa A; Halim M; Sahovic E; Gyger M; Chaudhri N; Al Mohareb F; Seth P; Aslam M; Aljurf M
Br J Haematol; 2000 Mar; 108(3):544-8. PubMed ID: 10759712
[TBL] [Abstract][Full Text] [Related]
77. [Successful treatment of pre-engraftment disseminated fusariosis with high-dose liposomal amphotericin B in a cord blood transplant recipient].
Harada Y; Murata M; Matsumoto A; Kato D; Yagi T; Yaguchi T; Yoshikawa T; Takeichi T; Akiyama M; Yamaguchi Y; Koyama D; Terakura S; Nishida T; Kiyoi H
Rinsho Ketsueki; 2019; 60(12):1641-1646. PubMed ID: 31902814
[TBL] [Abstract][Full Text] [Related]
78. Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children.
Ringdén O; Tollemar J
Mycoses; 1993; 36(5-6):187-92. PubMed ID: 8264715
[TBL] [Abstract][Full Text] [Related]
79. Conventional vs. liposomal amphotericin B in immunosuppressed children.
Zoubek A; Emminger W; Emminger-Schmidmeier W; Peters C; Pracher E; Grois N; Gadner H
Pediatr Hematol Oncol; 1992; 9(2):187-90. PubMed ID: 1524992
[TBL] [Abstract][Full Text] [Related]
80. Antifungal therapy in thoracic cancer patients with low dose liposomal amphotericin B (AmBisome).
Lequaglie C; Giudice G; Massone PP; Cataldo I
Int J Antimicrob Agents; 2000 Dec; 16(4):541-3. PubMed ID: 11118876
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
